Work Vitamins: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Work Vitamins
Largest movements
- Tangible fixed assets -€29,726
down €29,726 (-100.0%), from €29,726 to €0
- Receivables within one year -€10,144
down €10,144 (-89.6%), from €11,324 to €1,180
of which Other amounts receivable: -€10,410
- Cash +€3,683
up €3,683 (+80.7%), from €4,562 to €8,245
mainly Investment in fixed assets (net) (+€19,726) and Receivables within one year (+€10,144)
- Profit (loss) carried forward -€36,340
down €36,340 (-159.5%), from -€22,779 to -€59,119
- Other operating charges +€10,410
up €10,410, from €0 to €10,410
- Gross operating margin +€4,200
up €4,200, from -€285 to €3,915
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €45,612 | €9,424 | -€36,187 | -79.3% |
| Fixed assets | 21/28 | €29,726 | €0 | -€29,726 | -100.0% |
| Tangible fixed assets | 22/27 | €29,726 | €0 | -€29,726 | -100.0% |
| Plant, machinery and equipment | 23 | €29,726 | €0 | -€29,726 | -100.0% |
| Current assets | 29/58 | €15,886 | €9,424 | -€6,461 | -40.7% |
| Amounts receivable within one year | 40/41 | €11,324 | €1,180 | -€10,144 | -89.6% |
| Trade receivables | 40 | €0 | €266 | +€266 | |
| Other amounts receivable | 41 | €11,324 | €914 | -€10,410 | -91.9% |
| Cash at bank and in hand | 54/58 | €4,562 | €8,245 | +€3,683 | +80.7% |
| Total equity and liabilities | 10/49 | €45,612 | €9,424 | -€36,187 | -79.3% |
| Equity | 10/15 | €45,228 | €8,887 | -€36,340 | -80.4% |
| Contributions | 10/11 | €65,600 | €65,600 | = | 0.0% |
| Reserves | 13 | €2,406 | €2,406 | = | 0.0% |
| Distributable reserves | 133 | €2,406 | €2,406 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€22,779 | -€59,119 | -€36,340 | -159.5% |
| Amounts payable | 17/49 | €384 | €537 | +€153 | +39.8% |
| Amounts payable within one year | 42/48 | €384 | €537 | +€153 | +39.8% |
| Trade debts | 44 | €384 | €537 | +€153 | +39.8% |
| Suppliers | 440/4 | €384 | €537 | +€153 | +39.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €10,000 | €10,000 | = | 0.0% |
| Other operating charges | 640/8 | €0 | €10,410 | +€10,410 | |
| Non-recurring operating charges | 66A | - | €19,726 | +€19,726 | |
| Gross operating margin | 9900 | -€285 | €3,915 | +€4,200 | |
| Operating profit (loss) | 9901 | -€10,285 | -€36,222 | -€25,936 | -252.2% |
| Financial charges | 65/66B | €119 | €119 | = | 0.0% |
| Recurring financial charges | 65 | €119 | €119 | = | 0.0% |
| Profit (loss) for the period before taxes | 9903 | -€10,404 | -€36,340 | -€25,936 | -249.3% |
| Profit (loss) for the period | 9904 | -€10,404 | -€36,340 | -€25,936 | -249.3% |
| Profit (loss) for the period to be appropriated | 9905 | -€10,404 | -€36,340 | -€25,936 | -249.3% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 10 October 2026 via checked.be.